Document is current
Any future updates will be listed below
-
Authors
Morimoto, Keita https://orcid.org/0009-0003-0170-8297
Yamanaka, Shuichiro https://orcid.org/0000-0002-4741-1005
Matsui, Kenji https://orcid.org/0000-0003-2897-2285
Kinoshita, Yoshitaka https://orcid.org/0000-0002-6896-3407
Inage, Yuka https://orcid.org/0000-0002-4874-4215
Yamamoto, Shutaro
Koda, Nagisa
Matsumoto, Naoto
Saito, Yatsumu
Takamura, Tsuyoshi
Fujimoto, Toshinari https://orcid.org/0000-0002-4178-8645
Fukunaga, Shohei
Tajiri, Susumu
Matsumoto, Kei
Ozawa, Katsusuke
Wada, Seiji
Kobayashi, Eiji
Yokoo, Takashi https://orcid.org/0000-0003-1838-7998
- License Information
-
More Information
Article History
Received: 8 August 2024
Accepted: 19 February 2025
First Online: 3 March 2025
Competing interests
: Author Eiji Kobayashi is the director of Kobayashi Regenerative Research Institute, LLC. Eiji Kobayashi has received a research fund from Sumitomo Pharma Co., Ltd., Osaka, Japan as a result of the Collaborative Research Agreement between The Jikei University School of Medicine and Sumitomo Pharma Co., Ltd. Author Eiji Kobayashi have received technical guidance fee from Fuji Micra Inc., Shizuoka, Japan. The authors declare that this research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
